Craig W. Hendrix

1989–2025 年に発表

89
論文数
19,135
被引用数
56
h 指数
84
i10 指数

被引用数

Craig W. Hendrix の年別被引用数1988 年: 被引用 3 件1990 年: 被引用 2 件1991 年: 被引用 2 件1992 年: 被引用 3 件1993 年: 被引用 12 件1994 年: 被引用 66 件1995 年: 被引用 54 件1996 年: 被引用 67 件1997 年: 被引用 69 件1998 年: 被引用 54 件1999 年: 被引用 37 件2000 年: 被引用 29 件2001 年: 被引用 32 件2002 年: 被引用 34 件2003 年: 被引用 42 件2004 年: 被引用 26 件2005 年: 被引用 36 件2006 年: 被引用 42 件2007 年: 被引用 36 件2008 年: 被引用 44 件2009 年: 被引用 48 件2010 年: 被引用 60 件2011 年: 被引用 46 件2012 年: 被引用 53 件2013 年: 被引用 111 件2014 年: 被引用 178 件2015 年: 被引用 208 件2016 年: 被引用 220 件2017 年: 被引用 145 件2018 年: 被引用 167 件2019 年: 被引用 755 件2020 年: 被引用 588 件2021 年: 被引用 570 件2022 年: 被引用 482 件2023 年: 被引用 355 件2024 年: 被引用 547 件2025 年: 被引用 193 件2026 年: 被引用 4 件1989 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,098 件、この内訳の 39.3%南アフリカ: 引用元論文 383 件、この内訳の 7.2%イギリス: 引用元論文 359 件、この内訳の 6.7%ケニア: 引用元論文 192 件、この内訳の 3.6%カナダ: 引用元論文 161 件、この内訳の 3%ウガンダ: 引用元論文 158 件、この内訳の 3%スイス: 引用元論文 139 件、この内訳の 2.6%中国: 引用元論文 122 件、この内訳の 2.3%ベルギー: 引用元論文 111 件、この内訳の 2.1%フランス: 引用元論文 110 件、この内訳の 2.1%ドイツ: 引用元論文 108 件、この内訳の 2%イタリア: 引用元論文 104 件、この内訳の 1.9%
0%39.3%その他 24.2%

分野

  • Medicine71%
  • Immunology and Microbiology18%
  • Biochemistry, Genetics and Molecular Biology2.8%
  • Social Sciences1.9%
  • Health Professions1.3%
  • Pharmacology, Toxicology and Pharmaceutics1.2%
  • その他3.8%

トピック

  • HIV/AIDS Research and Interventions19.3%
  • HIV Research and Treatment8.7%
  • HIV, Drug Use, Sexual Risk8.1%
  • HIV/AIDS drug development and treatment6.4%
  • Adolescent Sexual and Reproductive Health5.2%
  • Sex work and related issues5.2%
  • その他47.1%

共著者

全論文

検索で開く
  1. Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Estelle Piwowar‐Manning, Mark A. Marzinke, Craig W. Hendrix, Maoji Li, Zhe Wang, Jeanne Marrazzo, Eric S. Daar, Aida Asmelash, Todd T. Brown, Peter L. Anderson, Susan H. Eshleman, Marcus Bryan, Cheryl Blanchette, Jonathan Lucas, Christina Psaros, Steven A. Safren, Jeremy Sugarman, Hyman Scott, Joseph J. Eron, Sheldon D. Fields, Nirupama Sista, Kailazarid Gomez-Feliciano, Andrea Jennings, Ryan Kofron, Timothy H. Holtz, Katherine Shin, James F. Rooney, Kimberly Y. Smith, William Spreen, David M. Margolis, Alex R. Rinehart, Adeola Adeyeye, Myron S. Cohen, Marybeth McCauley, Beatriz Grinsztejn - New England Journal of Medicine 2021 被引用: 853

  2. Cabotegravir for the prevention of HIV-1 in women: results from HPTN 084, a phase 3, randomised clinical trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Nirupama Sista, Adeola Adeyeye, James F. Rooney, Alex R. Rinehart, William Spreen, Kimberly Y. Smith, Brett Hanscom, Myron S. Cohen, Mina C. Hosseinipour, Aida Asmelash, Alice Sehurutshi, Allan Baguma, Anita Marais, Barbarah Kawoozo, Bongiwe Prudence Malinga, Brenda Gati Mirembe, Brenda Okech, Bryan Esterhuizen, Caroline Murombedzi, Daphne Gadama, Eldinah Hwengwere, Elizabeth Roos, Elizabeth S Magada, Emily Shava, Estelle Piwowar-Manning, Eunice Tahuringana, Felix GS Muhlanga, Francesca Conradie, Frank Angira, Gertrude Nanyonjo, Girisha Kistnasami, Hazzie Mvula, Ishana Naidoo, Jaco Horak, Jane Jere, Jeeva Moodley, Katie Shin, Kerry Nel, Kevin Bokoch, Lilian Birungi, Lynda Emel, Maletsatsi Monametsi, Marvelous Sibanda, Mercy Mutambanengwe, Miria Chitukuta, Moleen Matimbira, Muchaneta Bhondai-Mhuri, Ncamsile Sibisi, Neetha Morar, Netsai Mudzonga, Paul Natureeba, Paul Richardson, Petina Musara, Pippa Macdonald, Rejoice Nkambule, Repelang Mosime, Rhonda White, Ribka Berhanu, Ritha Ncube-Sihlongonyane, Rogers Sekabira, Samantha Siva, Saresha Pillay, Shamelle Govender, Sheiala Bamweyana, Siyabonga Nzimande, Steve Innes, Sufia Dadabhai, Taraz Samandari, Tchangani Tembo, Thandie Lungu Mabedi ほか 9 名 - The Lancet 2022 被引用: 540

  3. Antiretroviral Prophylaxis for HIV Prevention in Heterosexual Men and Women

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Meighan Krows, Jennifer Revall, Susan Morrison, Harald S. Haugen, Mira Emmanuel-Ogier, Lisa Ondrejcek, Robert W. Coombs, Lisa M. Frenkel, Craig W. Hendrix, Namandjé N. Bumpus, David R. Bangsberg, Jessica E. Haberer, Wendy Stevens, Jairam R. Lingappa, Connie Celum - New England Journal of Medicine 2012 被引用: 3,309

  4. Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ashley Mayo, Rachel Scheckter, Jennifer Berthiaume, Edward Livant, Cindy Jacobson, Patrick Ndase, Rhonda White, Karen Patterson, Donna Germuga, Beth Galaska, Katherine Bunge, Devika Singh, Daniel Szydlo, Elizabeth Montgomery, Barbara Mensch, Kristine Torjesen, Cynthia I. Grossman, Nahida Chakhtoura, Annaléne Nel, Zeda Rosenberg, Ian McGowan, Sharon L. Hillier - New England Journal of Medicine 2016 被引用: 764

  5. Antiretroviral prophylaxis for HIV infection in injecting drug users in Bangkok, Thailand (the Bangkok Tenofovir Study): a randomised, double-blind, placebo-controlled phase 3 trial

    著者: , , , , , , , , , , , , , , , , - The Lancet 2013 被引用: 1,494

  6. Antiretroviral Preexposure Prophylaxis for Heterosexual HIV Transmission in Botswana

    著者: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2012 被引用: 2,023

  7. Tenofovir-Based Preexposure Prophylaxis for HIV Infection among African Women

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 1,307

  8. Tail-phase safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in HIV-uninfected adults: a secondary analysis of the HPTN 077 trial

    著者: , , , , , , , , , , , , , , , , , , , , , - The Lancet HIV 2020 被引用: 171

  9. Adherence, safety, and choice of the monthly dapivirine vaginal ring or oral emtricitabine plus tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis among African adolescent girls and young women: a randomised, open-label, crossover trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Craig W. Hendrix, Peter L. Anderson, Kenneth Ngure - The Lancet HIV 2023 被引用: 60

  10. Efficacy and safety of long-acting cabotegravir compared with daily oral tenofovir disoproxil fumarate plus emtricitabine to prevent HIV infection in cisgender men and transgender women who have sex with men 1 year after study unblinding: a secondary analysis of the phase 2b and 3 HPTN 083 randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet HIV 2023 被引用: 65

  11. Characterization of Human Immunodeficiency Virus (HIV) Infection in Cisgender Men and Transgender Women Who Have Sex With Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Journal of Infectious Diseases 2021 被引用: 130

  12. Safety, uptake, and use of a dapivirine vaginal ring for HIV-1 prevention in African women (HOPE): an open-label, extension study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Yuqing Jiao, Craig W. Hendrix, Zvavahera M. Chirenje, Clemensia Nakabiito, Taha E. Taha, Judith Jones, Kristine Torjesen, Annaléne Nel, Zeda Rosenberg, Lydia Soto‐Torres, Sharon L. Hillier, Elizabeth R. Brown, Dorothy Aanyu, John Abima, Janne Abullarade, Priyanka Agarwal, Surabhi Ahluwalia, Simon Africa Akasiima, Carolyne A. Akello, Samuel Albert, Motsamai Alphale, Calins Alphonse, Lucy Apeduno, Sara Aranda, Orly Aridor, Shakeera Arnolds, Prossy Asiimwe, Millicent Atujuna, Didas Atwebembere, Lakshmi Baboolall, Kiran Badana, Jared M. Baeten, David Balamusani, Iván C. Balán, Gabriel Banda, Towera Whitney Banda, Jennifer Baugh, James Amos Baziira, May A. Beamer, Sivuyisiwe Asanda Bebeza, Linda‐Gail Bekker, Ian M. Bell, Meagan J. Bemer, Richard Berman, Jennifer Berthiaume, Linda Bezak, Yashveer Bhagwandin, Hassen Anwar Bhayat, Nokulunga Bhengu, Sonto Bhengu, Aruna Bhoola, Florence Asiimwe Biira, Daniel Bittoni, Roberta Black, Nombuso Jacqueline Blose, Pearl Boks, Stephen G. Bolton, Phathiswa Botya, Amanda Brown, Elizabeth R. Brown, Helen Brown, Robyn Helen Bruce, Luke Erismus Bukenya, Aidah Bukirwa, Katherine Bunge, Lisa Bunts, Fezile Buthelezi, Mbongeleni William Buthelezi, Samkelisiwe Dumisile Buthelezi, Rose Byogero ほか 690 名 - The Lancet HIV 2021 被引用: 111

  13. Safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir in low-risk HIV-uninfected individuals: HPTN 077, a phase 2a randomized controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2018 被引用: 172

  14. HIV Protective Efficacy and Correlates of Tenofovir Blood Concentrations in a Clinical Trial of PrEP for HIV Prevention

    著者: , , , , , , , , , , - JAIDS Journal of Acquired Immune Deficiency Syndromes 2014 被引用: 365

  15. Extended Analysis of HIV Infection in Cisgender Men and Transgender Women Who Have Sex with Men Receiving Injectable Cabotegravir for HIV Prevention: HPTN 083

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2023 被引用: 29

  16. Pharmacokinetics and Safety of AMD-3100, a Novel Antagonist of the CXCR-4 Chemokine Receptor, in Human Volunteers

    著者: , , , , , , , - Antimicrobial Agents and Chemotherapy 2000 被引用: 504

  17. Conceptual Design of a Universal Donor Screening Approach for Vaginal Microbiota Transplant

    著者: , , , , , , , , , , , , , - Frontiers in Cellular and Infection Microbiology 2019 被引用: 56

  18. Safety, Pharmacokinetics, and Antiviral Activity of AMD3100, a Selective CXCR4 Receptor Inhibitor, in HIV-1 Infection

    著者: , , , , , , , , , , , , , , - JAIDS Journal of Acquired Immune Deficiency Syndromes 2004 被引用: 362

  19. Daily and non-daily pre-exposure prophylaxis in African women (HPTN 067/ADAPT Cape Town Trial): a randomised, open-label, phase 2 trial

    著者: , , , , , , , , , , , , , , , , , - The Lancet HIV 2017 被引用: 118

  20. Greater dapivirine release from the dapivirine vaginal ring is correlated with lower risk of HIV‐1 acquisition: a secondary analysis from a randomized, placebo‐controlled trial

    著者: , , , , , , , , , , , - Journal of the International AIDS Society 2020 被引用: 78

  21. Integrated Delivery of Antiretroviral Treatment and Pre-exposure Prophylaxis to HIV-1–Serodiscordant Couples: A Prospective Implementation Study in Kenya and Uganda

    著者: , , , , , , , , , , , , , , , , , , , , , , - PLoS Medicine 2016 被引用: 213

  22. Pharmacokinetics of Long-Acting Tenofovir Alafenamide (GS-7340) Subdermal Implant for HIV Prophylaxis

    著者: , , , , , , , , , , - Antimicrobial Agents and Chemotherapy 2015 被引用: 165

  23. Characterization of Human Immunodeficiency Virus (HIV) Infections in Women Who Received Injectable Cabotegravir or Tenofovir Disoproxil Fumarate/Emtricitabine for HIV Prevention: HPTN 084

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brett Hanscom, Sinéad Delany‐Moretlwe, Mark A. Marzinke - The Journal of Infectious Diseases 2021 被引用: 69

  24. Multiparametric magnetic resonance imaging to characterize cabotegravir long‐acting formulation depot kinetics in healthy adult volunteers

    著者: , , , , , , , , , , , , , , , , , , , - British Journal of Clinical Pharmacology 2021 被引用: 33